Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...

Gain Therapeutics (GANX) provided a letter to shareholders from the Company’s President and CEO, Gene Mack, which read in part,”With 2025 ...

After hours: February 3 at 6:30:56 PM EST Loading Chart for GANX ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BETHESDA, Md. - Gain Therapeutics, Inc. (NASDAQ:GANX) announced today its intention to offer and sell shares of its common stock in an underwritten public offering. The biotech ...

Roche Holding AG Akt-0.20% CHF230.77B ...

Sanofi S.A. Part Cert 0.02% €8.03M ...

After hours: February 4 at 6:06:10 PM EST Loading Chart for CORT ...